Sage Therapeutics, Inc. (SAGE) has 63 open-market insider trades by 14 insiders since 2012. The most active filer is Jeffrey M. Jonas, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jeffrey M. Jonas | Dir | — | 12 | $131.2M | 2023-11-28 |
| Kevin P. Starr | Dir | — | 3 | $38.5M | 2021-06-16 |
| Steven M. Paul | Dir | — | 8 | $30.6M | 2022-11-28 |
| Albert Robichaud | CSO | — | 6 | $21.6M | 2023-02-03 |
| Stephen Kanes | — | — | 7 | $12.8M | 2021-10-19 |
| Kimi Iguchi | CFOTreasurer | — | 10 | $11.1M | 2024-08-05 |
| James M. Frates | Dir | — | 6 | $4.9M | 2025-07-31 |
| Michael Cloonan | — | — | 1 | $4.4M | 2019-07-25 |
| Barry E. Greene | CEOPres | — | 3 | $2.5M | 2025-07-31 |
| Anne Marie Cook | VPSecretary | — | 1 | $2.5M | 2024-08-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Elizabeth Barrett | Director | Buy | $37K | 2023-08-09 |
| Elizabeth Barrett | Director | Buy | $51K | 2023-05-09 |
| Jeffrey M. Jonas | Director | Sell | $1.0M | 2023-02-10 |
| Barry E. Greene | CEO & President | Buy | $1000K | 2022-11-10 |
| George Golumbeski | Director | Buy | $252K | 2022-05-05 |
| Barry E. Greene | CEO & President | Buy | $1.0M |
Companies that share insiders with SAGE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-08-05 |
| Kevin P. Starr | Director | Buy | $2.0M | 2021-06-16 |
| Barry E. Greene | CEO & President | Buy | $496K | 2021-06-16 |
| James M. Frates | Director | Buy | $100K | 2021-06-16 |
| Jeffrey M. Jonas | CEO & President | Buy | $482K | 2019-12-09 |
| Albert Robichaud | CSO | Buy | $1.6M | 2019-12-09 |
| James M. Frates | Director | Sell | $1.3M | 2019-08-15 |
| Jeffrey M. Jonas | CEO & President | Sell | $150K | 2019-05-29 |
| Jeffrey M. Jonas | CEO & President | Sell | $29.9M | 2019-05-28 |
| Jeffrey M. Jonas | CEO & President | Sell | $14.8M | 2019-05-28 |